<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144/A</submissionType>
    <previousAccessionNumber>0001966249-24-000017</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001638474</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001597264</issuerCik>
      <issuerName>Blueprint Medicines Corp</issuerName>
      <secFileNumber>001-37359</secFileNumber>
      <issuerAddress>
        <com:street1>45 Sidney Street</com:street1>
        <com:city>Cambridge</com:city>
        <com:stateOrCountry>MA</com:stateOrCountry>
        <com:zipCode>02139</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>617-374-7580</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Albers Jeffrey W.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Director</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Citigroup Global Markets Inc.</name>
        <address>
          <com:street1>388 Greenwich Street</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10013</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>5000</noOfUnitsSold>
      <aggregateMarketValue>510000.00</aggregateMarketValue>
      <noOfUnitsOutstanding>6114723</noOfUnitsOutstanding>
      <approxSaleDate>11/07/2024</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <acquiredDate>02/16/2017</acquiredDate>
      <natureOfAcquisitionTransaction>Grant of vested options</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>5000</amountOfSecuritiesAcquired>
      <paymentDate>02/16/2021</paymentDate>
      <natureOfPayment>Compensation for services</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Albers, Jeffrey W.</name>
        <address>
          <com:street1>c/o Blueprint Medicines Corp.</com:street1>
          <com:street2>45 Sydney Street</com:street2>
          <com:city>Cambridge</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02139</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>09/09/2024</saleDate>
      <amountOfSecuritiesSold>19702</amountOfSecuritiesSold>
      <grossProceeds>1685911.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <remarks>Amended to correct acquisition details concerning the shares sold hereunder.</remarks>
    <noticeSignature>
      <noticeDate>11/12/2024</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>05/08/2024</planAdoptionDate>
      </planAdoptionDates>
      <signature>/s/ Aegis J. Frumento as a duly authorized representative of Citigroup Global Markets Inc., as attorney-in-fact for JEFFREY W. ALBERS</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
